Wells Fargo & Company Biolase, Inc Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
$0.07 - $0.34 $2 - $11
33 Added 19.76%
200 $0
Q1 2023

May 12, 2023
BUY
$0.28 - $0.75 $33 - $88
118 Added 240.82%
167 $0
Q4 2022

Feb 13, 2023
BUY
$0.59 - $2.5 $1 - $7
3 Added 6.52%
49 $0
Q3 2022

Nov 14, 2022
BUY
$2.43 - $5.53 $12 - $27
5 Added 12.2%
46 $0
Q2 2022

Aug 12, 2022
BUY
$3.42 - $8.75 $140 - $358
41 New
41 $0

Others Institutions Holding BIOL

# of Institutions
2
Shares Held
56
Call Options Held
0
Put Options Held
0
View Full List

About BIOLASE, INC

BIOL Quotes by TradingView
  • Ticker BIOL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,260,180
  • Market Cap $82.6K
  • Description
  • BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive de...
More about BIOL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email